Senate committee postpones vote on whether to advance CDC director nominee
Summary
The Senate health committee delayed a vote on advancing Dr. Erica Schwartz’s nomination to lead the Centers for Disease Control and Prevention (CDC). The vote will take place next week after the committee resolves attendance issues, and if confirmed, Schwartz will become the CDC’s new director.Key Facts
- The Senate health committee postponed the vote due to a family emergency affecting Republican attendance.
- Dr. Erica Schwartz is nominated to be the 22nd CDC director.
- The CDC is based in Atlanta and focuses on protecting Americans from health threats.
- Schwartz faced questions about resisting political pressure during her confirmation hearing.
- Sen. Bill Cassidy supports Schwartz, believing she can stand up to pressure from Health Secretary Robert F. Kennedy Jr.
- The CDC has experienced leadership changes and staff losses since President Donald Trump returned to office last year.
- Other high-level health positions, including surgeon general and FDA commissioner, are also vacant.
- Another nominee, Sean Kaufman, is being considered for assistant secretary for preparedness and response but has faced criticism over vaccination statements; his vote is scheduled for later.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
